

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 6.03883544 |
| 2 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.85378983 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 5.41612463 |
| 4 | protein-lipid complex assembly (GO:0065005) | 5.11294141 |
| 5 | regulation of apoptotic cell clearance (GO:2000425) | 5.02447932 |
| 6 | low-density lipoprotein particle remodeling (GO:0034374) | 4.98221857 |
| 7 | regulation of fibrinolysis (GO:0051917) | 4.96530120 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.29609099 |
| 9 | plasma lipoprotein particle clearance (GO:0034381) | 4.27817072 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 4.23065623 |
| 11 | negative regulation of protein activation cascade (GO:2000258) | 4.21317015 |
| 12 | regulation of cholesterol homeostasis (GO:2000188) | 4.01121929 |
| 13 | plasma lipoprotein particle organization (GO:0071827) | 3.96544432 |
| 14 | protein-lipid complex subunit organization (GO:0071825) | 3.88799167 |
| 15 | pinocytosis (GO:0006907) | 3.85888770 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 3.84371064 |
| 17 | macromolecular complex remodeling (GO:0034367) | 3.84371064 |
| 18 | plasma lipoprotein particle remodeling (GO:0034369) | 3.84371064 |
| 19 | regulation of cholesterol esterification (GO:0010872) | 3.84188577 |
| 20 | regulation of plasminogen activation (GO:0010755) | 3.76175371 |
| 21 | surfactant homeostasis (GO:0043129) | 3.73384281 |
| 22 | positive regulation of extracellular matrix organization (GO:1903055) | 3.69096670 |
| 23 | intestinal cholesterol absorption (GO:0030299) | 3.66987416 |
| 24 | chemical homeostasis within a tissue (GO:0048875) | 3.58590536 |
| 25 | negative regulation of complement activation (GO:0045916) | 3.55586677 |
| 26 | cellular response to growth hormone stimulus (GO:0071378) | 3.45746446 |
| 27 | growth hormone receptor signaling pathway (GO:0060396) | 3.41782234 |
| 28 | fibrinolysis (GO:0042730) | 3.29949623 |
| 29 | iron ion import (GO:0097286) | 3.22466867 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.20772928 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.20772928 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.20772928 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.20772928 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.20772928 |
| 35 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.20772928 |
| 36 | lipoprotein metabolic process (GO:0042157) | 3.19897385 |
| 37 | acute-phase response (GO:0006953) | 3.18217152 |
| 38 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.15605809 |
| 39 | skin morphogenesis (GO:0043589) | 3.12688994 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 3.10831063 |
| 41 | positive regulation of bone remodeling (GO:0046852) | 3.09322555 |
| 42 | positive regulation of bone resorption (GO:0045780) | 3.09322555 |
| 43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.09286764 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 3.08598862 |
| 45 | cellular response to interferon-alpha (GO:0035457) | 3.04411756 |
| 46 | COPII vesicle coating (GO:0048208) | 3.02108804 |
| 47 | oligosaccharide catabolic process (GO:0009313) | 3.00452432 |
| 48 | regulation of macrophage chemotaxis (GO:0010758) | 2.99107691 |
| 49 | hypotonic response (GO:0006971) | 2.98919372 |
| 50 | hepatocyte apoptotic process (GO:0097284) | 2.97138284 |
| 51 | regulation of humoral immune response (GO:0002920) | 2.96077575 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 2.95290643 |
| 53 | positive regulation of lipid storage (GO:0010884) | 2.94725437 |
| 54 | alpha-linolenic acid metabolic process (GO:0036109) | 2.94619540 |
| 55 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.93285269 |
| 56 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.92542907 |
| 57 | positive regulation of phagocytosis (GO:0050766) | 2.90974755 |
| 58 | protein activation cascade (GO:0072376) | 2.90740957 |
| 59 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.89108742 |
| 60 | reverse cholesterol transport (GO:0043691) | 2.88257172 |
| 61 | regulation of cholesterol storage (GO:0010885) | 2.87635214 |
| 62 | sterol transport (GO:0015918) | 2.87428671 |
| 63 | cholesterol transport (GO:0030301) | 2.87428671 |
| 64 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.86854601 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 2.85074339 |
| 66 | negative regulation of sterol transport (GO:0032372) | 2.85074339 |
| 67 | negative regulation of blood coagulation (GO:0030195) | 2.84590697 |
| 68 | negative regulation of hemostasis (GO:1900047) | 2.84590697 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 2.83630204 |
| 70 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.81263475 |
| 71 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81015280 |
| 72 | phospholipid efflux (GO:0033700) | 2.80738370 |
| 73 | complement activation, classical pathway (GO:0006958) | 2.80148310 |
| 74 | response to manganese ion (GO:0010042) | 2.80129440 |
| 75 | mammary gland epithelial cell proliferation (GO:0033598) | 2.78002604 |
| 76 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.77588217 |
| 77 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.76436214 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.76373390 |
| 79 | negative regulation of coagulation (GO:0050819) | 2.75077435 |
| 80 | regulation of interferon-alpha production (GO:0032647) | 2.74537540 |
| 81 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.71396092 |
| 82 | negative regulation of humoral immune response (GO:0002921) | 2.70050825 |
| 83 | negative regulation of wound healing (GO:0061045) | 2.70049447 |
| 84 | negative regulation of lipid storage (GO:0010888) | 2.69943470 |
| 85 | positive regulation of steroid metabolic process (GO:0045940) | 2.68737098 |
| 86 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67576890 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.67156246 |
| 88 | positive regulation of blood coagulation (GO:0030194) | 2.66251816 |
| 89 | positive regulation of hemostasis (GO:1900048) | 2.66251816 |
| 90 | response to host immune response (GO:0052572) | 2.66228724 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66228724 |
| 92 | positive regulation of wound healing (GO:0090303) | 2.66001775 |
| 93 | intestinal absorption (GO:0050892) | 2.65930021 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64852953 |
| 95 | hyaluronan metabolic process (GO:0030212) | 2.64325303 |
| 96 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.63756564 |
| 97 | macrophage activation involved in immune response (GO:0002281) | 2.62967697 |
| 98 | Golgi transport vesicle coating (GO:0048200) | 2.62649859 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 2.62649859 |
| 100 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.61826893 |
| 101 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61591773 |
| 102 | negative regulation of cell killing (GO:0031342) | 2.61591773 |
| 103 | platelet degranulation (GO:0002576) | 2.60491622 |
| 104 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.58734001 |
| 105 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.56974512 |
| 106 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56353149 |
| 107 | protein carboxylation (GO:0018214) | 2.56121323 |
| 108 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.56121323 |
| 109 | osteoclast differentiation (GO:0030316) | 2.55837393 |
| 110 | complement activation (GO:0006956) | 2.55117611 |
| 111 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55094373 |
| 112 | basement membrane organization (GO:0071711) | 2.54732155 |
| 113 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.53398283 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.52854523 |
| 115 | positive regulation of coagulation (GO:0050820) | 2.52203262 |
| 116 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.52184766 |
| 117 | response to host (GO:0075136) | 2.52184766 |
| 118 | response to host defenses (GO:0052200) | 2.52184766 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.52118004 |
| 120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.52118004 |
| 121 | regulation of metalloenzyme activity (GO:0048552) | 2.51797076 |
| 122 | myeloid dendritic cell differentiation (GO:0043011) | 2.50953723 |
| 123 | regulation of bile acid biosynthetic process (GO:0070857) | 2.47421674 |
| 124 | nucleobase catabolic process (GO:0046113) | 2.47105930 |
| 125 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.46344842 |
| 126 | natural killer cell mediated immunity (GO:0002228) | 2.45443411 |
| 127 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.45443411 |
| 128 | nuclear pore complex assembly (GO:0051292) | 2.45341113 |
| 129 | regulation of acute inflammatory response (GO:0002673) | 2.44804053 |
| 130 | regulation of extracellular matrix organization (GO:1903053) | 2.43964997 |
| 131 | positive regulation of macrophage differentiation (GO:0045651) | 2.41234952 |
| 132 | low-density lipoprotein particle clearance (GO:0034383) | 2.40641994 |
| 133 | endodermal cell differentiation (GO:0035987) | 2.40621954 |
| 134 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.40004091 |
| 135 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.39513896 |
| 136 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.38353861 |
| 137 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.35763276 |
| 138 | estrogen biosynthetic process (GO:0006703) | 2.35349950 |
| 139 | lung lobe morphogenesis (GO:0060463) | 2.34864268 |
| 140 | response to growth hormone (GO:0060416) | 2.34699842 |
| 141 | substrate-dependent cell migration (GO:0006929) | 2.34395872 |
| 142 | complement activation, alternative pathway (GO:0006957) | 2.34165844 |
| 143 | cellular response to antibiotic (GO:0071236) | 2.33348307 |
| 144 | phagosome maturation (GO:0090382) | 2.32737331 |
| 145 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.32328486 |
| 146 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.29424587 |
| 147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.29310016 |
| 148 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.29310016 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.29005642 |
| 150 | trivalent inorganic cation transport (GO:0072512) | 2.28715429 |
| 151 | ferric iron transport (GO:0015682) | 2.28715429 |
| 152 | detection of molecule of bacterial origin (GO:0032490) | 2.28077172 |
| 153 | cellular response to ethanol (GO:0071361) | 2.27538763 |
| 154 | urea metabolic process (GO:0019627) | 2.27314705 |
| 155 | urea cycle (GO:0000050) | 2.27314705 |
| 156 | apoptotic cell clearance (GO:0043277) | 2.27298475 |
| 157 | clathrin coat assembly (GO:0048268) | 2.26688305 |
| 158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.25849446 |
| 159 | regulation of natural killer cell differentiation (GO:0032823) | 2.22190062 |
| 160 | response to xenobiotic stimulus (GO:0009410) | 2.22056054 |
| 161 | phenylpropanoid metabolic process (GO:0009698) | 2.21088424 |
| 162 | I-kappaB phosphorylation (GO:0007252) | 2.19996027 |
| 163 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.18225305 |
| 164 | transferrin transport (GO:0033572) | 2.17969486 |
| 165 | positive regulation of interferon-beta production (GO:0032728) | 2.17652958 |
| 166 | regulation of protein activation cascade (GO:2000257) | 2.17495781 |
| 167 | NLS-bearing protein import into nucleus (GO:0006607) | 2.16996046 |
| 168 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.16588817 |
| 169 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.16581508 |
| 170 | reactive oxygen species biosynthetic process (GO:1903409) | 2.15940016 |
| 171 | epoxygenase P450 pathway (GO:0019373) | 2.15876567 |
| 172 | type B pancreatic cell proliferation (GO:0044342) | 2.15332046 |
| 173 | axon extension (GO:0048675) | 2.14500330 |
| 174 | macrophage activation (GO:0042116) | 2.12681445 |
| 175 | regulation of complement activation (GO:0030449) | 2.11968702 |
| 176 | protein localization to microtubule (GO:0035372) | 2.11118781 |
| 177 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.10628579 |
| 178 | regulation of alkaline phosphatase activity (GO:0010692) | 2.10626962 |
| 179 | protein localization to endosome (GO:0036010) | 2.08636975 |
| 180 | cholesterol efflux (GO:0033344) | 2.08435122 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.01576796 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.70940331 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.34057072 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.32881754 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.19789629 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.03397196 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.91343258 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.83020563 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61200263 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.50632882 |
| 11 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.48500857 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.46038242 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.39200045 |
| 14 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.34274898 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31122857 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.29175362 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.28981377 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28336671 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20294002 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.17249299 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12030743 |
| 22 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.07529415 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.07529415 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.03502201 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.95587992 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.90592155 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89525499 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89390493 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.88705299 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86908369 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86462356 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83217591 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.81845626 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.78037834 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68590672 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.67246334 |
| 37 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66588486 |
| 38 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66588486 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.65768955 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.64416053 |
| 41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.63567237 |
| 42 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63565699 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63249731 |
| 44 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.62041712 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58791480 |
| 46 | RXR_22108803_ChIP-Seq_LS180_Human | 1.57864804 |
| 47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.57032249 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55228241 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54898416 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53850148 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52102978 |
| 52 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51949346 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51505364 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51064477 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47426747 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47335994 |
| 57 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45541535 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41427220 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.40054027 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39215953 |
| 61 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37298921 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37218107 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.36663990 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35517744 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34269452 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34245481 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34119543 |
| 68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.33933717 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30578159 |
| 70 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.30313182 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29695429 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28797687 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28057153 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27864515 |
| 75 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26362925 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.26143247 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24858760 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22538418 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20630227 |
| 80 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20597764 |
| 81 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19488908 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18740247 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.18541945 |
| 84 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16884437 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15259279 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14597305 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14406440 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13647362 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13411901 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11800333 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11751107 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11586372 |
| 93 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09208762 |
| 94 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.08653212 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08516314 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08382018 |
| 97 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07360398 |
| 98 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07048846 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06703461 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06454244 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05647204 |
| 102 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05639655 |
| 103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05126508 |
| 104 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03150015 |
| 105 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02299543 |
| 106 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01503999 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01495729 |
| 108 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.01044883 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00569655 |
| 110 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99527416 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98547420 |
| 112 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98047682 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97616911 |
| 114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97351585 |
| 115 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97057279 |
| 116 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96204615 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95762013 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95411283 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95329019 |
| 120 | MYB_26560356_Chip-Seq_TH2_Human | 0.95308360 |
| 121 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.95097111 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94869726 |
| 123 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94569735 |
| 124 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93667525 |
| 125 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92318211 |
| 126 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91801463 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90657798 |
| 128 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87766920 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87292117 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86627430 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85952068 |
| 132 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.82948343 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82704691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 3.56703808 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.08447983 |
| 3 | MP0003303_peritoneal_inflammation | 2.90969332 |
| 4 | MP0005451_abnormal_body_composition | 2.85077508 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.62482868 |
| 6 | MP0003950_abnormal_plasma_membrane | 2.58270490 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.54889603 |
| 8 | MP0003436_decreased_susceptibility_to | 2.50654046 |
| 9 | MP0003122_maternal_imprinting | 2.40837343 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.38589326 |
| 11 | MP0001881_abnormal_mammary_gland | 2.37297104 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.34502019 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.29895758 |
| 14 | MP0003724_increased_susceptibility_to | 2.28849163 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.20593529 |
| 16 | MP0004272_abnormal_basement_membrane | 2.17060626 |
| 17 | MP0003195_calcinosis | 2.16726306 |
| 18 | MP0001915_intracranial_hemorrhage | 2.11635684 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.10976099 |
| 20 | MP0009785_altered_susceptibility_to | 1.86851299 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.85321344 |
| 22 | MP0000604_amyloidosis | 1.84022199 |
| 23 | MP0000569_abnormal_digit_pigmentation | 1.83462375 |
| 24 | MP0005083_abnormal_biliary_tract | 1.81894344 |
| 25 | MP0000627_abnormal_mammary_gland | 1.80199301 |
| 26 | MP0005085_abnormal_gallbladder_physiolo | 1.78236674 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.75945613 |
| 28 | MP0005076_abnormal_cell_differentiation | 1.75854170 |
| 29 | MP0006082_CNS_inflammation | 1.72475939 |
| 30 | MP0002419_abnormal_innate_immunity | 1.69689926 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.66473732 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.63315873 |
| 33 | MP0005164_abnormal_response_to | 1.60348281 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.60200063 |
| 35 | MP0001958_emphysema | 1.60130022 |
| 36 | MP0004947_skin_inflammation | 1.58875856 |
| 37 | MP0003091_abnormal_cell_migration | 1.53585439 |
| 38 | MP0001790_abnormal_immune_system | 1.53521197 |
| 39 | MP0005387_immune_system_phenotype | 1.53521197 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.50136308 |
| 41 | MP0002006_tumorigenesis | 1.49571453 |
| 42 | MP0003868_abnormal_feces_composition | 1.48995239 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.48310352 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.48002341 |
| 45 | MP0005409_darkened_coat_color | 1.47471404 |
| 46 | MP0001177_atelectasis | 1.45422612 |
| 47 | MP0008260_abnormal_autophagy | 1.43193092 |
| 48 | MP0004883_abnormal_blood_vessel | 1.41003820 |
| 49 | MP0005166_decreased_susceptibility_to | 1.39025100 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.38965648 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.38822354 |
| 52 | MP0003448_altered_tumor_morphology | 1.38723524 |
| 53 | MP0000858_altered_metastatic_potential | 1.38418703 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.32953333 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.32527929 |
| 56 | MP0009764_decreased_sensitivity_to | 1.31371049 |
| 57 | MP0004858_abnormal_nervous_system | 1.30194748 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.29266705 |
| 59 | MP0010307_abnormal_tumor_latency | 1.27903856 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.26161906 |
| 61 | MP0003075_altered_response_to | 1.25754087 |
| 62 | MP0005025_abnormal_response_to | 1.23659458 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 1.22651078 |
| 64 | MP0000767_abnormal_smooth_muscle | 1.21495829 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.17626235 |
| 66 | MP0003045_fibrosis | 1.17236910 |
| 67 | MP0002168_other_aberrant_phenotype | 1.17137166 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.16002967 |
| 69 | MP0003252_abnormal_bile_duct | 1.14992035 |
| 70 | MP0002254_reproductive_system_inflammat | 1.14865337 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.12959445 |
| 72 | MP0005360_urolithiasis | 1.12567750 |
| 73 | MP0010329_abnormal_lipoprotein_level | 1.12167026 |
| 74 | MP0005023_abnormal_wound_healing | 1.11399369 |
| 75 | MP0003221_abnormal_cardiomyocyte_apopto | 1.10913085 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 1.08471060 |
| 77 | MP0001845_abnormal_inflammatory_respons | 1.08456043 |
| 78 | MP0005408_hypopigmentation | 1.07539086 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07196994 |
| 80 | MP0002933_joint_inflammation | 1.07143192 |
| 81 | MP0002009_preneoplasia | 1.06592587 |
| 82 | MP0005623_abnormal_meninges_morphology | 1.06590690 |
| 83 | MP0003690_abnormal_glial_cell | 1.05573195 |
| 84 | MP0010368_abnormal_lymphatic_system | 1.04796342 |
| 85 | MP0000920_abnormal_myelination | 1.04695908 |
| 86 | MP0002295_abnormal_pulmonary_circulatio | 1.04561982 |
| 87 | MP0003828_pulmonary_edema | 1.03619097 |
| 88 | MP0002723_abnormal_immune_serum | 1.03388564 |
| 89 | MP0001800_abnormal_humoral_immune | 1.01601582 |
| 90 | MP0003123_paternal_imprinting | 1.01058093 |
| 91 | MP0008469_abnormal_protein_level | 0.99954729 |
| 92 | MP0001542_abnormal_bone_strength | 0.99617628 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.99268625 |
| 94 | MP0005671_abnormal_response_to | 0.98322405 |
| 95 | MP0004130_abnormal_muscle_cell | 0.97173877 |
| 96 | MP0005365_abnormal_bile_salt | 0.96432497 |
| 97 | MP0009053_abnormal_anal_canal | 0.96073988 |
| 98 | MP0005248_abnormal_Harderian_gland | 0.95014196 |
| 99 | MP0000609_abnormal_liver_physiology | 0.94033987 |
| 100 | MP0001819_abnormal_immune_cell | 0.92806478 |
| 101 | MP0001853_heart_inflammation | 0.91928983 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.91693366 |
| 103 | MP0006054_spinal_hemorrhage | 0.90680271 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.90637312 |
| 105 | MP0004510_myositis | 0.89473713 |
| 106 | MP0002405_respiratory_system_inflammati | 0.89285149 |
| 107 | MP0000685_abnormal_immune_system | 0.88949602 |
| 108 | MP0005310_abnormal_salivary_gland | 0.88899484 |
| 109 | MP0000343_altered_response_to | 0.88853549 |
| 110 | MP0009840_abnormal_foam_cell | 0.88288608 |
| 111 | MP0002133_abnormal_respiratory_system | 0.87309517 |
| 112 | MP0005388_respiratory_system_phenotype | 0.87309517 |
| 113 | MP0001661_extended_life_span | 0.86497557 |
| 114 | MP0008004_abnormal_stomach_pH | 0.85848646 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.82266977 |
| 116 | MP0009763_increased_sensitivity_to | 0.81685893 |
| 117 | MP0003941_abnormal_skin_development | 0.81155373 |
| 118 | MP0003279_aneurysm | 0.81099246 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.80597150 |
| 120 | MP0005275_abnormal_skin_tensile | 0.79891144 |
| 121 | MP0000249_abnormal_blood_vessel | 0.79596693 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.79139091 |
| 123 | * MP0002118_abnormal_lipid_homeostasis | 0.78965014 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.77748488 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.77747377 |
| 126 | MP0001851_eye_inflammation | 0.75873805 |
| 127 | MP0003329_amyloid_beta_deposits | 0.74978629 |
| 128 | MP0000371_diluted_coat_color | 0.74959399 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.74872320 |
| 130 | MP0004270_analgesia | 0.74457446 |
| 131 | MP0000598_abnormal_liver_morphology | 0.73099288 |
| 132 | MP0002971_abnormal_brown_adipose | 0.72024995 |
| 133 | MP0004233_abnormal_muscle_weight | 0.71717887 |
| 134 | MP0009384_cardiac_valve_regurgitation | 0.71588161 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.70433028 |
| 136 | MP0003632_abnormal_nervous_system | 0.70408930 |
| 137 | MP0002086_abnormal_extraembryonic_tissu | 0.67291901 |
| 138 | MP0005165_increased_susceptibility_to | 0.66936372 |
| 139 | MP0005621_abnormal_cell_physiology | 0.65145224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 5.35007354 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 3.84070232 |
| 3 | Osteolytic defects of the hand bones (HP:0009699) | 3.69834847 |
| 4 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.69834847 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.53349650 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.40992234 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 3.37744038 |
| 8 | Alveolar cell carcinoma (HP:0006519) | 3.36275606 |
| 9 | Myocardial infarction (HP:0001658) | 3.33978282 |
| 10 | Hypercholesterolemia (HP:0003124) | 3.20565113 |
| 11 | Subacute progressive viral hepatitis (HP:0006572) | 3.17050021 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.13838516 |
| 13 | Menorrhagia (HP:0000132) | 3.06371036 |
| 14 | Disinhibition (HP:0000734) | 3.03765717 |
| 15 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.03235204 |
| 16 | Complement deficiency (HP:0004431) | 2.91685223 |
| 17 | Abnormality of carpal bone ossification (HP:0006257) | 2.90722908 |
| 18 | Gingival bleeding (HP:0000225) | 2.89363339 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.85816490 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.78757076 |
| 21 | Scanning speech (HP:0002168) | 2.71336429 |
| 22 | Flat acetabular roof (HP:0003180) | 2.70080229 |
| 23 | Nephritis (HP:0000123) | 2.69454503 |
| 24 | Abnormality of complement system (HP:0005339) | 2.65137709 |
| 25 | Skin nodule (HP:0200036) | 2.63822454 |
| 26 | Mutism (HP:0002300) | 2.63793596 |
| 27 | Premature rupture of membranes (HP:0001788) | 2.63211255 |
| 28 | Small epiphyses (HP:0010585) | 2.61301506 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.55721233 |
| 30 | Myositis (HP:0100614) | 2.50549938 |
| 31 | Hematochezia (HP:0002573) | 2.46830342 |
| 32 | Cardiovascular calcification (HP:0011915) | 2.43723110 |
| 33 | Abnormality of the lumbar spine (HP:0100712) | 2.42776483 |
| 34 | Orchitis (HP:0100796) | 2.41412673 |
| 35 | Arterial thrombosis (HP:0004420) | 2.40307008 |
| 36 | Deep venous thrombosis (HP:0002625) | 2.40283778 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.40101636 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.39086085 |
| 39 | Vascular calcification (HP:0004934) | 2.38088042 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.37827676 |
| 41 | Purpura (HP:0000979) | 2.37518081 |
| 42 | Pustule (HP:0200039) | 2.37136286 |
| 43 | Abnormal ossification of hand bones (HP:0005921) | 2.32795562 |
| 44 | Thick nail (HP:0001805) | 2.30243406 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.29333350 |
| 46 | Acanthocytosis (HP:0001927) | 2.28248463 |
| 47 | Epidermoid cyst (HP:0200040) | 2.27967682 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.27262707 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.26769714 |
| 50 | Flared iliac wings (HP:0002869) | 2.26425635 |
| 51 | Esophageal varix (HP:0002040) | 2.25952208 |
| 52 | Absent frontal sinuses (HP:0002688) | 2.25299559 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.22960278 |
| 54 | Inappropriate behavior (HP:0000719) | 2.20870479 |
| 55 | Optic neuritis (HP:0100653) | 2.20269834 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.20269834 |
| 57 | Tetraparesis (HP:0002273) | 2.18934250 |
| 58 | Broad palm (HP:0001169) | 2.18531511 |
| 59 | Mitral stenosis (HP:0001718) | 2.17887162 |
| 60 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17481309 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17481309 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17481309 |
| 63 | Short nail (HP:0001799) | 2.16646324 |
| 64 | Amyloidosis (HP:0011034) | 2.16470613 |
| 65 | Gout (HP:0001997) | 2.14979259 |
| 66 | Stomach cancer (HP:0012126) | 2.13306982 |
| 67 | Peritonitis (HP:0002586) | 2.12798215 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.12338901 |
| 69 | Tubulointerstitial fibrosis (HP:0005576) | 2.12240103 |
| 70 | Papilledema (HP:0001085) | 2.10304955 |
| 71 | Enlarged penis (HP:0000040) | 2.09938190 |
| 72 | Curly hair (HP:0002212) | 2.08774113 |
| 73 | Abnormal hand bone ossification (HP:0010660) | 2.07243999 |
| 74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.06772375 |
| 75 | Mucopolysacchariduria (HP:0008155) | 2.06772375 |
| 76 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.06731240 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 2.04042046 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02797143 |
| 79 | Glomerulonephritis (HP:0000099) | 2.02280594 |
| 80 | Osteomyelitis (HP:0002754) | 2.01715475 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.01589611 |
| 82 | Syringomyelia (HP:0003396) | 2.01464899 |
| 83 | Spinal cord lesions (HP:0100561) | 2.01464899 |
| 84 | Joint swelling (HP:0001386) | 2.01222889 |
| 85 | Abnormal foot bone ossification (HP:0010675) | 2.00333887 |
| 86 | Abnormality of macrophages (HP:0004311) | 1.98601312 |
| 87 | Periodontitis (HP:0000704) | 1.98344438 |
| 88 | Cupped ribs (HP:0000887) | 1.98231332 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 1.98174204 |
| 90 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97335909 |
| 91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96305361 |
| 92 | Focal segmental glomerulosclerosis (HP:0000097) | 1.95933122 |
| 93 | Abnormality of the acetabulum (HP:0003170) | 1.95623494 |
| 94 | Abnormal tarsal ossification (HP:0008369) | 1.95409065 |
| 95 | Cerebral aneurysm (HP:0004944) | 1.95337028 |
| 96 | Epiphyseal dysplasia (HP:0002656) | 1.94995752 |
| 97 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.93991608 |
| 98 | Xanthomatosis (HP:0000991) | 1.93850771 |
| 99 | Dysostosis multiplex (HP:0000943) | 1.93832734 |
| 100 | Cutaneous melanoma (HP:0012056) | 1.92479168 |
| 101 | Hypoalphalipoproteinemia (HP:0003233) | 1.91207025 |
| 102 | Aortic dissection (HP:0002647) | 1.90416476 |
| 103 | Arterial tortuosity (HP:0005116) | 1.90178179 |
| 104 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89725956 |
| 105 | Diminished motivation (HP:0000745) | 1.89426189 |
| 106 | Prostate neoplasm (HP:0100787) | 1.88700515 |
| 107 | Cortical dysplasia (HP:0002539) | 1.87883642 |
| 108 | Apathy (HP:0000741) | 1.85193091 |
| 109 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84192928 |
| 110 | Thrombophlebitis (HP:0004418) | 1.84164852 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.83627815 |
| 112 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.83627815 |
| 113 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.83627815 |
| 114 | Orthostatic hypotension (HP:0001278) | 1.83317001 |
| 115 | Hepatocellular carcinoma (HP:0001402) | 1.82662723 |
| 116 | Metaphyseal irregularity (HP:0003025) | 1.82578369 |
| 117 | Glomerulosclerosis (HP:0000096) | 1.80314727 |
| 118 | Vertebral compression fractures (HP:0002953) | 1.79550518 |
| 119 | Wormian bones (HP:0002645) | 1.79266617 |
| 120 | Broad alveolar ridges (HP:0000187) | 1.79239251 |
| 121 | Ovoid vertebral bodies (HP:0003300) | 1.79029542 |
| 122 | Vacuolated lymphocytes (HP:0001922) | 1.78889854 |
| 123 | Epistaxis (HP:0000421) | 1.78220682 |
| 124 | Upper motor neuron abnormality (HP:0002127) | 1.77325354 |
| 125 | Conjunctival telangiectasia (HP:0000524) | 1.75889689 |
| 126 | Polycythemia (HP:0001901) | 1.75003837 |
| 127 | Coarse hair (HP:0002208) | 1.74760360 |
| 128 | Abnormal delivery (HP:0001787) | 1.74692054 |
| 129 | Striae distensae (HP:0001065) | 1.73823517 |
| 130 | Intrahepatic cholestasis (HP:0001406) | 1.73330983 |
| 131 | Lower limb amyotrophy (HP:0007210) | 1.73312392 |
| 132 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.72050446 |
| 133 | Abnormality of the wing of the ilium (HP:0011867) | 1.71369009 |
| 134 | Viral hepatitis (HP:0006562) | 1.70874481 |
| 135 | Bone pain (HP:0002653) | 1.70791645 |
| 136 | Aortic aneurysm (HP:0004942) | 1.70592204 |
| 137 | Micronodular cirrhosis (HP:0001413) | 1.70259865 |
| 138 | Gingivitis (HP:0000230) | 1.68276973 |
| 139 | Spontaneous abortion (HP:0005268) | 1.67821822 |
| 140 | Cervical subluxation (HP:0003308) | 1.67386536 |
| 141 | Vascular tortuosity (HP:0004948) | 1.66801630 |
| 142 | Gastrointestinal infarctions (HP:0005244) | 1.65964130 |
| 143 | Alopecia of scalp (HP:0002293) | 1.65630366 |
| 144 | Long toe (HP:0010511) | 1.64172307 |
| 145 | Increased mean platelet volume (HP:0011877) | 1.64024469 |
| 146 | Pathologic fracture (HP:0002756) | 1.63844935 |
| 147 | Asymmetry of the thorax (HP:0001555) | 1.61514882 |
| 148 | Abnormality of the pericardium (HP:0001697) | 1.61425858 |
| 149 | Cerebral inclusion bodies (HP:0100314) | 1.61061636 |
| 150 | Keratoconjunctivitis sicca (HP:0001097) | 1.60755840 |
| 151 | Akinesia (HP:0002304) | 1.58861871 |
| 152 | Anorexia (HP:0002039) | 1.58351409 |
| 153 | Camptodactyly of toe (HP:0001836) | 1.58344962 |
| 154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.57980833 |
| 155 | Joint hemorrhage (HP:0005261) | 1.57288552 |
| 156 | Acrocyanosis (HP:0001063) | 1.57212778 |
| 157 | Mucosal telangiectasiae (HP:0100579) | 1.57066665 |
| 158 | Abnormal cortical bone morphology (HP:0003103) | 1.56973102 |
| 159 | Overgrowth (HP:0001548) | 1.56757781 |
| 160 | Aqueductal stenosis (HP:0002410) | 1.56704518 |
| 161 | Abnormality of pain sensation (HP:0010832) | 1.55880557 |
| 162 | Impaired pain sensation (HP:0007328) | 1.55880557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.01395443 |
| 2 | MAP3K14 | 3.23942449 |
| 3 | FRK | 2.94364643 |
| 4 | BMPR2 | 2.75107367 |
| 5 | PLK2 | 2.68246879 |
| 6 | ICK | 2.56988566 |
| 7 | ERBB3 | 2.49190542 |
| 8 | DDR2 | 2.44341533 |
| 9 | SCYL2 | 2.43065494 |
| 10 | NEK9 | 2.27579306 |
| 11 | CASK | 2.18901077 |
| 12 | PRPF4B | 2.18444716 |
| 13 | RIPK4 | 2.18145152 |
| 14 | MAP3K9 | 2.15771876 |
| 15 | DAPK2 | 2.15756206 |
| 16 | FGFR3 | 2.10541479 |
| 17 | STK24 | 2.05150886 |
| 18 | JAK3 | 2.00784990 |
| 19 | CDK12 | 1.92878967 |
| 20 | FGR | 1.77515076 |
| 21 | FER | 1.69204398 |
| 22 | AKT3 | 1.67471280 |
| 23 | MST4 | 1.61108083 |
| 24 | STK3 | 1.60510638 |
| 25 | WNK1 | 1.54426481 |
| 26 | EPHA2 | 1.53580713 |
| 27 | MAP3K2 | 1.50073867 |
| 28 | SGK3 | 1.48945236 |
| 29 | SGK2 | 1.47246695 |
| 30 | MST1R | 1.46229518 |
| 31 | FGFR4 | 1.46159086 |
| 32 | MATK | 1.41224117 |
| 33 | LATS1 | 1.38158627 |
| 34 | CDK6 | 1.37852936 |
| 35 | JAK1 | 1.36643595 |
| 36 | ZAP70 | 1.35668420 |
| 37 | MAP2K3 | 1.34437690 |
| 38 | LATS2 | 1.32917706 |
| 39 | TYRO3 | 1.31599331 |
| 40 | TRPM7 | 1.30865945 |
| 41 | SIK1 | 1.26427385 |
| 42 | EPHA3 | 1.21862938 |
| 43 | NUAK1 | 1.21551257 |
| 44 | TAOK2 | 1.21070842 |
| 45 | NTRK1 | 1.21048729 |
| 46 | CDC42BPA | 1.20703191 |
| 47 | MAP3K6 | 1.20491253 |
| 48 | PLK3 | 1.16858077 |
| 49 | TBK1 | 1.09476956 |
| 50 | CHUK | 1.08048408 |
| 51 | CSK | 1.06349060 |
| 52 | MAP3K12 | 1.03287640 |
| 53 | MARK1 | 1.03150554 |
| 54 | MINK1 | 1.01903930 |
| 55 | EIF2AK1 | 1.00884743 |
| 56 | TXK | 0.98954308 |
| 57 | TYK2 | 0.98170291 |
| 58 | PKN2 | 0.93364152 |
| 59 | EIF2AK3 | 0.92480478 |
| 60 | WNK4 | 0.91138159 |
| 61 | SIK3 | 0.90767744 |
| 62 | TGFBR2 | 0.89802060 |
| 63 | PDPK1 | 0.88955324 |
| 64 | IKBKB | 0.88630063 |
| 65 | JAK2 | 0.87075840 |
| 66 | MAP2K1 | 0.86920510 |
| 67 | PDGFRB | 0.86898965 |
| 68 | EPHB2 | 0.86636062 |
| 69 | EGFR | 0.86256637 |
| 70 | STK10 | 0.86175671 |
| 71 | MAP3K3 | 0.85988856 |
| 72 | MOS | 0.84527601 |
| 73 | BMX | 0.83968508 |
| 74 | YES1 | 0.83849220 |
| 75 | MAP3K1 | 0.83300583 |
| 76 | ERN1 | 0.81516518 |
| 77 | FGFR2 | 0.79871331 |
| 78 | PTK2 | 0.78259989 |
| 79 | LRRK2 | 0.78033623 |
| 80 | MELK | 0.77331748 |
| 81 | CAMK1D | 0.75972278 |
| 82 | PAK4 | 0.75372102 |
| 83 | IKBKE | 0.73594030 |
| 84 | BLK | 0.72529231 |
| 85 | GSK3A | 0.72225370 |
| 86 | FGFR1 | 0.71095784 |
| 87 | ARAF | 0.71041653 |
| 88 | RET | 0.70841921 |
| 89 | PRKAA2 | 0.70583043 |
| 90 | PIK3CA | 0.69318492 |
| 91 | PIM2 | 0.68953316 |
| 92 | ERBB4 | 0.68746688 |
| 93 | KSR2 | 0.67994291 |
| 94 | MET | 0.67761215 |
| 95 | RPS6KA2 | 0.66605423 |
| 96 | DAPK1 | 0.65964693 |
| 97 | BCR | 0.65958698 |
| 98 | EEF2K | 0.65758055 |
| 99 | PDK1 | 0.65178446 |
| 100 | CAMK1G | 0.64735874 |
| 101 | PAK2 | 0.63402394 |
| 102 | MAP3K13 | 0.62352229 |
| 103 | PAK3 | 0.61541142 |
| 104 | SGK223 | 0.60411552 |
| 105 | SGK494 | 0.60411552 |
| 106 | RIPK1 | 0.59834763 |
| 107 | CLK1 | 0.58993780 |
| 108 | PDK2 | 0.57464542 |
| 109 | CAMKK2 | 0.57422390 |
| 110 | CSNK1G2 | 0.57086713 |
| 111 | PTK6 | 0.56597614 |
| 112 | STK38L | 0.53503621 |
| 113 | PRKCH | 0.52536470 |
| 114 | BRD4 | 0.51479914 |
| 115 | IRAK4 | 0.51404115 |
| 116 | ALK | 0.51341353 |
| 117 | MAPK11 | 0.51148360 |
| 118 | CCNB1 | 0.49811335 |
| 119 | CAMKK1 | 0.49029779 |
| 120 | CSF1R | 0.48825699 |
| 121 | MAP3K5 | 0.48699597 |
| 122 | EPHB1 | 0.48434783 |
| 123 | CSNK1A1L | 0.47237973 |
| 124 | KSR1 | 0.45719802 |
| 125 | ITK | 0.44711138 |
| 126 | MAP2K4 | 0.44660287 |
| 127 | FLT3 | 0.43948819 |
| 128 | GRK7 | 0.43754425 |
| 129 | EIF2AK2 | 0.43473211 |
| 130 | IGF1R | 0.42687997 |
| 131 | MAP3K8 | 0.42512776 |
| 132 | BRSK2 | 0.42339481 |
| 133 | PIM1 | 0.41572291 |
| 134 | NEK1 | 0.41521616 |
| 135 | TRIB3 | 0.41291500 |
| 136 | TTN | 0.40856238 |
| 137 | PRKCE | 0.40361896 |
| 138 | PDGFRA | 0.40189257 |
| 139 | SYK | 0.39010344 |
| 140 | ABL1 | 0.38864822 |
| 141 | MTOR | 0.38284905 |
| 142 | RAF1 | 0.37012691 |
| 143 | DYRK1B | 0.36863867 |
| 144 | INSR | 0.34420684 |
| 145 | CDK4 | 0.31833419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.93797770 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41396761 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.10379719 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10170414 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98333008 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 1.90940206 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.82449471 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.79598069 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78886744 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61206992 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60890733 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.58517229 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.56516761 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51363779 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.50519946 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.50255206 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.44949264 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.44529629 |
| 19 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.44284038 |
| 20 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.42782641 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39206574 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39027833 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38137791 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.34351232 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.31401805 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.30987458 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29514519 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27692962 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26017275 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.25668585 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22887249 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.22335718 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22242623 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22115500 |
| 35 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19828429 |
| 36 | Endometrial cancer_Homo sapiens_hsa05213 | 1.19252140 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.18207253 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.17595974 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17353425 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16767857 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12463249 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10144126 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08407227 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06717619 |
| 45 | Measles_Homo sapiens_hsa05162 | 1.04954526 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04602080 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.03173954 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01112220 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.01098378 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.00946419 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99991593 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99117107 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.95625073 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94063654 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.93990929 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93379244 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93101613 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.92846718 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91825460 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90001818 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85233998 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.85011701 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84614961 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84239311 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84007841 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.83683448 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82424264 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82388073 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.81537592 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80741829 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.79228359 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79206001 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78881870 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78126791 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78123075 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77768077 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77485406 |
| 78 | Focal adhesion_Homo sapiens_hsa04510 | 0.76026956 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.75099923 |
| 80 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74909056 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.74061636 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73422983 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72737190 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72098255 |
| 85 | * Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.72069220 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70384344 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69984343 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68300289 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67763034 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66431386 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64639265 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64620983 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63779505 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62951199 |
| 95 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62789482 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62511243 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59637990 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59212799 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58694174 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57470085 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57313570 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56612486 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56179729 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55658673 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55543524 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55207099 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55007456 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54613039 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54446494 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.53746299 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53652189 |
| 112 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53627214 |
| 113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52255646 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51624579 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51164914 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.49218380 |
| 117 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48928484 |
| 118 | Melanoma_Homo sapiens_hsa05218 | 0.48525631 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.47918652 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.45845190 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44650246 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44339181 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43720874 |
| 124 | Bile secretion_Homo sapiens_hsa04976 | 0.43675765 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42587582 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41603752 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41432088 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40866358 |
| 129 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40610121 |

